Cotinga Pharmaceuticalsの時価総額
Cotinga Pharmaceuticalsの時価総額は何ですか。
Cotinga Pharmaceuticals, Inc.の時価総額は605.64k$です。
時価総額の定義は何ですか。
時価総額は、取引された会社の発行済株式の市場価値であり、一定期間のb株式に発行済株式数を掛けたものに等しい。
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
TSXVのセクタHealth Careにおける時価総額の企業と比べるCotinga Pharmaceuticals
Cotinga Pharmaceuticalsは何をしますか。
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Cotinga Pharmaceuticalsと類似の時価総額
- IR Resourcesの時価総額は595.62k$です。
- Sherpa IIの時価総額は595.97k$です。
- Universal Office Automationの時価総額は596.66k$です。
- Cann-Is Capitalの時価総額は596.79k$です。
- Catenae Innovation Plcの時価総額は604.22k$です。
- Foodbaseの時価総額は604.64k$です。
- Cotinga Pharmaceuticalsの時価総額は605.64k$です。
- Tomizoneの時価総額は606.35k$です。
- Personas Socialの時価総額は609.14k$です。
- Transition Opportunities Corpの時価総額は610.04k$です。
- Blue Rhino Capitalの時価総額は610.53k$です。
- Gravity (India)の時価総額は611.31k$です。
- Pacific Silk Road Resourcesの時価総額は612.75k$です。